国产热热热精品,亚洲视频久久】日韩,三级婷婷在线久久,99人妻精品视频,精品九热人人肉肉在线,AV东京热一区二区,91po在线视频观看,久久激情宗合,青青草黄色手机视频

   

/ Top News

Investigation paves way to cut drug prices
By Zhang Feng(China Daily)
Updated: 2006-05-02 06:55

Some drug prices in China will be reduced after the National Development and Reform Commission announces the results of a week-long investigation into some drug production and importation costs.

The commission recently conducted the probe, the first of its kind in China, on 21 pharmaceutical factories that produce Western medicine and seven that make traditional Chinese medicine. The producers are both domestic and foreign-invested.

Some companies involved in drug imports were also investigated.

The result of the investigation has not been released yet. The purpose is to ease the financial burden on patients.

Pharmaceutical factories commonly jack up the prices of their products to gain huge profits, and those soaring prices have been blamed as a key reason for the hefty costs of medical treatment.

The commission will use the investigation findings to launch a national campaign to reduce drug prices, which will cover 130 kinds of Western and at least 30 traditional Chinese medicines, the commission said.

Prices of anti-virus and anti-cancer drugs will be included for the first time. Also, producers of some traditional Chinese medicines, whose prices are generally considered affordable, will be asked to reduce their prices for the first time.

Despite 17 rounds of price cuts usually by 20 to 40 per cent covering more than 1,500 kinds of medicines in the past few years, people continue to say the costs of medical service and medicine are unaffordable.

One reason is that in the past, it was easy for producers to register a new name for their medicines. Each time the government asked them to reduce the price of a certain kind of medicine, they would simply re-register it as a "new drug" under a different name.

Even though the "new" drug was just as effective as the old one, the producer sold it at much higher prices.

Another problem is rampant bribery in dealings between drug traders and hospitals. Working as agents of pharmaceutical companies, these traders bribed hospitals and doctors to prescribe their expensive medicines instead of cheaper ones.

The result has been an outcry to authorities to regulate the drug marketing process. In some cases the retail price of the drugs was 10 times what it cost to produce.

Last month, the State Food and Drug Administration opened a centre to oversee new drug registration.

(China Daily 05/02/2006 page1)

 
 

云阳县| 都江堰市| 郎溪县| 临武县| 万宁市| 靖西县| 新郑市| 徐州市| 新平| 雷山县| 蒙山县| 桐乡市| 枣强县| 施秉县| 弋阳县| 武乡县| 东源县| 盖州市| 金阳县| 巴彦县| 清镇市| 通化市| 云阳县| 高碑店市| 砚山县| 黑山县| 临高县| 韩城市| 宝清县| 陆河县| 房产| 濉溪县| 万州区| 武乡县| 渑池县| 汉中市| 丹东市| 南康市| 金堂县| 疏勒县| 长治市|